Marvel Biosciences Corp's total assets for Q3 2024 were C$347.27K, a decrease of -51.17% from the previous quarter. TSE:MRVL total liabilities were C$3.10M for the fiscal quarter, a -1.93% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.